InvestorsHub Logo
Followers 66
Posts 2140
Boards Moderated 0
Alias Born 03/04/2018

Re: BAR123 post# 464329

Wednesday, 07/17/2024 8:34:18 AM

Wednesday, July 17, 2024 8:34:18 AM

Post# of 464659
Here's the link -34% in PM

https://www.cassavasciences.com/news-releases/news-release-details/cassava-sciences-announces-changes-executive-leadership-enhanced

They have two large P3 studies fully enrolled. Similar to A273, the drug seems reasonably safe. I would expect the human trials to continue as the issues that led to this decision affect pre-clinical research. If the P3's fail, the company is over.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News